HT
DRNA

HAP Trading’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

HAP Trading’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,300
Closed -$62K – 3026
2021
Q3 		$62K Buy
+11,300
New +$312K ﹤0.01% 1444

Other funds holding DRNA

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

HAP Trading's DRNA Position: Q4 2021 in Review

HAP Trading sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 16,352 shares — an estimated $330K sold.

HAP Trading first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $330K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

  • HAP Trading reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 16,352 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $330K.
  • HAP Trading first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
  • HAP Trading's Dicerna Pharmaceuticals, Inc. position peaked at $330K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.